Clinical Trial Update: Ultra Curto (Ultra Short) TB Prevention Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update for Ultra Curto, a short-course therapy for preventing tuberculosis, with the study now completed and results posted on 2025-06-19. The spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Ultra Curto

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis | Phase 4 | Status: COMPLETED | Results posted: 2025-06-19